CIDSCON 2025 emphasized a multi-faceted approach to tackle AMR
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
Moderna's updated COVID-19 mRNA vaccine will be available for the 2025-2026 vaccination season, pending a European Commission authorization decision
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Subscribe To Our Newsletter & Stay Updated